Insider Transactions in Q3 2023 at Xtant Medical Holdings, Inc. (XTNT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2023
|
Mark A. Schallenberger Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
116,144
+36.15%
|
-
|
|
Aug 15
2023
|
Scott C Neils Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,246
-4.85%
|
$25,246
$1.18 P/Share
|
|
Aug 15
2023
|
Scott C Neils Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
116,144
+18.25%
|
-
|
|
Aug 15
2023
|
Sean E Browne President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
174,216
+9.39%
|
-
|
|
Aug 15
2023
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,880
-6.05%
|
$49,880
$1.18 P/Share
|
|
Aug 15
2023
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,499
+12.76%
|
-
|
|
Aug 15
2023
|
Stavros G. Vizirgianakis Director |
BUY
Grant, award, or other acquisition
|
Direct |
217,770
+3.39%
|
-
|
|
Aug 15
2023
|
Lori D Mitchell Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+43.19%
|
-
|
|
Aug 15
2023
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+19.69%
|
-
|
|
Aug 15
2023
|
Jonn R. Beeson Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+42.4%
|
-
|
|
Aug 15
2023
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
145,180
+19.65%
|
-
|